Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk B Mendel

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|November 19, 2002
Mechanism by which mutations at his274 alter sensitivity of influenza a virus n1 neuraminidase to oseltamivir carboxylate and zanamivirMichael Z Wang, Chun Y Tai, Dirk B Mendel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2015
CCR 20th Anniversary Commentary: Determining a Pharmacokinetic/Pharmacodynamic Relationship for Sunitinib—A Look BackDirk B Mendel, Julie M Cherrington, A Douglas Laird
Journal of the American Society of Nephrology : JASN|March 7, 2000
Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1Edmund S Ho, Deborah C Lin, Dirk B Mendel, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2003
Hair depigmentation is a biological readout for pharmacological inhibition of KIT in mice and humansKatherine G Moss, Guy C Toner, Julie M Cherrington, et al.
Blood|July 2, 2002
Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitorsAlbert T Liao, May B Chien, Narmada Shenoy, et al.
Molecular Cancer Therapeutics|May 16, 2003
Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cellsA Douglas Laird, Guangmin Li, Katherine G Moss, et al.
Molecular Cancer Therapeutics|May 30, 2006
Contribution of individual targets to the antitumor efficacy of the multitargeted receptor tyrosine kinase inhibitor SU11248Olga Potapova, A Douglas Laird, Michelle A Nannini, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2006
Novel robust hepatitis C virus mouse efficacy modelQing Zhu, Yoko Oei, Dirk B Mendel, et al.
BMC Nephrology|June 3, 2014
Comparison of AMG 416 and cinacalcet in rodent models of uremiaSarah Walter, Amos Baruch, Shawn T Alexander, et al.
Expert Review of Vaccines|September 24, 2013
Translational sciences approach to RSV vaccine developmentVanessa Kurzweil, Roderick Tang, Mark Galinski, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|November 19, 2002
Mechanism by which mutations at his274 alter sensitivity of influenza a virus n1 neuraminidase to oseltamivir carboxylate and zanamivirMichael Z Wang, Chun Y Tai, Dirk B Mendel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2015
CCR 20th Anniversary Commentary: Determining a Pharmacokinetic/Pharmacodynamic Relationship for Sunitinib—A Look BackDirk B Mendel, Julie M Cherrington, A Douglas Laird
Journal of the American Society of Nephrology : JASN|March 7, 2000
Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1Edmund S Ho, Deborah C Lin, Dirk B Mendel, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2003
Hair depigmentation is a biological readout for pharmacological inhibition of KIT in mice and humansKatherine G Moss, Guy C Toner, Julie M Cherrington, et al.
Blood|July 2, 2002
Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitorsAlbert T Liao, May B Chien, Narmada Shenoy, et al.
Molecular Cancer Therapeutics|May 16, 2003
Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cellsA Douglas Laird, Guangmin Li, Katherine G Moss, et al.
Molecular Cancer Therapeutics|May 30, 2006
Contribution of individual targets to the antitumor efficacy of the multitargeted receptor tyrosine kinase inhibitor SU11248Olga Potapova, A Douglas Laird, Michelle A Nannini, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2006
Novel robust hepatitis C virus mouse efficacy modelQing Zhu, Yoko Oei, Dirk B Mendel, et al.
BMC Nephrology|June 3, 2014
Comparison of AMG 416 and cinacalcet in rodent models of uremiaSarah Walter, Amos Baruch, Shawn T Alexander, et al.
Expert Review of Vaccines|September 24, 2013
Translational sciences approach to RSV vaccine developmentVanessa Kurzweil, Roderick Tang, Mark Galinski, et al.
Pageof 2